Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly active MS (HAMS), poses a number of difficult problems for specialists, including not only the choice of a highly effective disease-modifying drug for MS (DMDMS), but also conditions for the timely and s...

全面介绍

书目详细资料
Main Authors: N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
格式: 文件
语言:Russian
出版: IMA-PRESS LLC 2020-10-01
丛编:Неврология, нейропсихиатрия, психосоматика
主题:
highly active multiple sclerosis
disease-modifying drugs for multiple sclerosis
cladribine tablets
在线阅读:https://nnp.ima-press.net/nnp/article/view/1459

因特网

https://nnp.ima-press.net/nnp/article/view/1459

相似书籍